Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Vitamin D Therapy Market Growth in 2025?

The vitamin d therapy market has experienced swift expansion in the past few years. The market, which stood at $2.92 billion in 2024, is projected to swell to $3.27 billion in 2025, marking a compound annual growth rate (CAGR) of 12.1%. Factors contributing to growth during this period include heightened awareness about vitamin D deficiency, a rise in bone disorders, an aging population, increased occurrence of osteoporosis, encouraging results from scientific studies, an upsurge in lifestyle-associated diseases, and medical endorsements for supplementation.

What Is the Forecast for the Vitamin D Therapy Market Size Through 2029?

The market for vitamin D therapy is projected to witness a significant upturn in the nearing years, with an estimated increment to $5.44 billion by 2029, at a compound annual growth rate (CAGR) of 13.6%. The surge in the projected timeframe can be ascribed to ongoing awareness and education, the swelling geriatric population, the inclusion of vitamin D in managing chronic diseases, advancements in formulation technology, global health endeavors, and an amplified emphasis on tailored nutrition. Key trends within this period encompass broadening applications beyond osteal health, state-led initiatives for supplementation, advances in formulation and dispensing techniques, emphasis on clinical studies and evidence-based methods, and expansion of the global market.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8810&type=smp

What are the Key Market Players in Vitamin D Therapy Market and How They’re Evolving?

Major companies operating in the vitamin d therapy market are Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Pfizer Inc., Merck & Co Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Biotics Research Corporation, Solvay Pharma India Pvt. Ltd., Forgo Pharmaceuticals Ltd., Mankind Pharmaceuticals Pvt. Ltd., Cipla Ltd., Ortho Molecular Products, Zhejiang Garden Biochemical High-tech Co. Ltd., Glenmark Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Mylan N.V., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Biocare Medical LLC, Mitsubishi Chemical Group, Zydus Cadila, DSM Nutritional Products AG, BASF SE, Fermenta Biotech Ltd., Taizhou Hisound Pharmaceutical Co. Ltd.

What Are the Primary Growth Drivers in the Vitamin D Therapy Market?

Due to the rising number of malnutrition cases, it is anticipated that the vitamin D therapy market will experience considerable growth. Malnutrition encompasses a range of issues, from inadequate to excessive nutrient intake, imbalances in essential nutrients, or trouble utilizing nutrients effectively. In malnourished hospital patients, a considerable prevalence of vitamin D deficiency can often be observed, which is closely linked to increased long-term mortality rates, especially when such patients aren’t under vitamin D treatment. Therefore, an increase in malnutrition cases drives a higher demand for vitamin D therapy. For instance, in 2024, the World Health Organization, an agency based in Switzerland that works towards enhancing global health, ensuring world safety, and supporting vulnerable communities, reported that in 2022, an estimated 390 million people around the globe, aged 18 and above, were underweight. At the same time, 2.5 billion people were overweight, including 890 million with obesity. In the 5-19-year age category, 390 million children and adolescents were overweight, including 160 million dealing with obesity. Additionally, 190 million were experiencing thinness while an estimated 149 million children below 5 years were stunted, and 37 million were overweight or obese. Undernutrition is associated with nearly half of the deaths in children under 5. Hence, the rising incidence of malnutrition is fueling the growth of the vitamin D therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8810&type=smp

What Are the Leading Segments in the Global Vitamin D Therapy Industry?

The vitamin d therapy market covered in this report is segmented –

1) By Administration: Oral, Parenteral

2) By Purchasing: OTC Drugs, Prescription Drugs

3) By Age Group: Children, Adults, Senior Adults

4) By Application: Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders

Subsegments:

1) By Oral: Vitamin D3 Supplements (Cholecalciferol), Vitamin D2 Supplements (Ergocalciferol), Vitamin D Fortified Foods And Beverages

2) By Parenteral: Injectable Vitamin D3 (Cholecalciferol), Injectable Vitamin D2 (Ergocalciferol), Intravenous Vitamin D Preparations

What Are the Key Market Trends in the Vitamin D Therapy Industry?

One prevailing trend in the vitamin D therapy market is the emphasis on product innovations. To maintain their market dominance, prominent companies in this sector are constantly debuting inventive products. For example, Cadila Pharmaceuticals Pvt Ltd, a multinational pharmaceutical firm based in India, set a new standard in treating Vitamin D deficiency by unveiling the first aqueous formulation, the Aqueous Cholecalciferol Injection, in February 2024. This innovation offers a distinctive solution capable of quickly correcting Vitamin D deficiency. Notably, the product exhibits better pharmacokinetics (PK) and pharmacodynamics (PD) compared to the conventional oil-based cholecalciferol alternatives in the marketplace.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report

What Is the Regional Outlook for the Vitamin D Therapy Market?

North America was the largest region in the vitamin D therapy market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin D therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8810

This Report Delivers Insight On:

1. How big is the vitamin d therapy market, and how is it changing globally?

2. Who are the major companies in the vitamin d therapy market, and how are they performing?

3. What are the key opportunities and risks in the vitamin d therapy market right now?

4. Which products or customer segments are growing the most in the vitamin d therapy market?

5. What factors are helping or slowing down the growth of the vitamin d therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model